Welcome to the fall issue of the Carlat Child Psychiatry Report. This issue will help you assess and manage substance use disorders in teens. It features interviews with cutting-edge people: Dr. Sandra Gomez-Luna on the outpatient management of opiate use; Dr. Gabriella Gobbi on the impact of cannabis, its interaction with depression, and the conundrum of cannabis withdrawal; and Dr. Elizabeth D’Amico on the efficacy, training, and implementation of outpatient motivational interviewing for substance use with teens. The issue also discusses assessment, treatment planning, and prevention for children and teens at risk for suicide, with a follow-up on the problematic impact of the television series 13 Reasons Why. In addition, we hope you’re enjoying the podcast episodes I’ve recorded with my clinical colleague Mara Goverman (search for Carlat on your podcast store). We’ve posted episodes on 13 Reasons Why and school refusal. We aspire to be the “Click and Clack” of child and adolescent mental health: clear and also really fun to listen to! Our job at Carlat is to offer accurate and useful content, and I welcome your feedback. Feel free to email me; it’s always good to hear from you.
KarXT (Cobenfy) is the first antipsychotic that doesn’t block dopamine. We trace the origins of this new drug to a South Asian herb used for over 5,000 years, up to the three...